Aamal’s Ebn Sina Medical partners with BeiGene to expand oncology offerings in Qatar

QATAR—Ebn Sina Medical, a subsidiary of Aamal Company Q.P.S.C. and a leading supplier of pharmaceutical, hospital, and healthcare products in Qatar, has entered into a strategic partnership with BeiGene, a global oncology company.

This collaboration aims to enhance the availability of cutting-edge cancer treatments in Qatar, marking a significant step forward for the country’s healthcare sector.

The agreement was formalized during a signing ceremony attended by prominent figures, including Aamal’s CEO, Mr. Rashid bin Ali Al Mansoori; Ebn Sina Medical’s General Manager, Dr. Essam Faragalla; and BeiGene’s General Manager for the Middle East and North Africa (MENA) region, Mr. Mohammed Al-Kapany.

Under this partnership, Ebn Sina Medical will act as BeiGene’s local partner and distributor in Qatar, ensuring that innovative oncology medicines efficiently reach healthcare providers and patients.

This partnership underscores Ebn Sina Medical’s dedication to delivering high-quality medical products to the local market.

Speaking about the collaboration, Aamal Company CEO Mr. Al Mansoori highlighted its importance in strengthening Qatar’s healthcare system by improving access to advanced cancer treatments.

He expressed confidence that this alliance would positively impact patient care and further solidify Ebn Sina Medical’s reputation as a trusted partner for leading global pharmaceutical companies.

Dr. Essam Faragalla added that this partnership with BeiGene represents a significant milestone in expanding access to advanced oncology therapies in Qatar.

He emphasized Ebn Sina Medical’s commitment to supporting healthcare professionals with the tools they need to enhance patient outcomes.

He noted that through such strategic collaborations, the company aims to continuously strengthen Qatar’s healthcare system and provide better treatment options for patients facing complex medical challenges.

From BeiGene’s perspective, Mr. Mohammed Al-Kapany expressed the company’s commitment to making innovative and affordable cancer treatments accessible to more patients worldwide.

He stated that this partnership reflects a shared vision with Ebn Sina Medical to improve outcomes for individuals living with cancer in Qatar.

Together, both organizations are working to ensure that patients and healthcare providers have timely access to high-quality therapies.

This strategic alliance aligns seamlessly with Ebn Sina Medical’s mission of enhancing patient care by providing access to world-class medicinal products while addressing the evolving needs of Qatar’s healthcare sector.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.